Inventor · disambiguated record
Daniel C. Pevear
Also filed as: PEVEAR DANIEL · PEVEAR DANIEL C
37 granted patents·18 pending applications·402 citations·filing 1997–2024
98Inventor score
Top patents by PatentIndex Score
55 records- 0198US9511142B2Beta-lactamase inhibitorsVENATORX PHARMACEUTICALS INC·Filed 2015·Granted Dec 6, 2016·50 cites·19 claims
- 0297US11638715B2Orally-bioavailable nucleoside analogsVENATORX PHARMACEUTICALS INC·Filed 2022·Granted May 2, 2023·9 cites·30 claims
- 0396US10669290B2Beta-lactamase inhibitorsVENATORX PHARMACEUTICALS INC·Filed 2019·Granted Jun 2, 2020·8 cites·18 claims
- 0496US9783555B2Beta-lactamase inhibitorsVENATORX PHARMACEUTICALS INC·Filed 2017·Granted Oct 10, 2017·15 cites·20 claims
- 0596US9376454B2Beta-lactamase inhibitorsVENATORX PHARMACEUTICALS INC·Filed 2015·Granted Jun 28, 2016·24 cites·20 claims
- 0696US9040504B2Beta-lactamase inhibitorsVENATORX PHARMACEUTICALS INC·Filed 2014·Granted May 26, 2015·34 cites·18 claims
- 0796US8912169B2Beta-lactamase inhibitorsVENATORX PHARMACEUTICALS INC·Filed 2013·Granted Dec 16, 2014·34 cites·20 claims
- 0895US9828391B2Beta-lactamase inhibitorsVENATORX PHARMACEUTICALS INC·Filed 2016·Granted Nov 28, 2017·15 cites·16 claims
- 0995US9802966B2Beta-lactamase inhibitorsVENATORX PHARMACEUTICALS INC·Filed 2016·Granted Oct 31, 2017·10 cites·20 claims
- 1095US9637504B2Beta-lactamase inhibitorsVENATORX PHARMACEUTICALS INC·Filed 2016·Granted May 2, 2017·19 cites·18 claims
- 1195US9403850B2Beta-lactamase inhibitorsVENATORX PHARMACEUTICALS INC·Filed 2014·Granted Aug 2, 2016·25 cites·20 claims
- 1294US10294248B2Beta-lactamase inhibitorsVENATORX PHARMACEUTICALS INC·Filed 2018·Granted May 21, 2019·7 cites·20 claims
- 1394US10214547B2Beta-lactamase inhibitorsVENATORX PHARMACEUTICALS INC·Filed 2017·Granted Feb 26, 2019·10 cites·10 claims
- 1494US9771382B2Beta-lactamase inhibitorsVENATORX PHARMACEUTICALS INC·Filed 2016·Granted Sep 26, 2017·15 cites·19 claims
- 1594US9422314B2Beta-lactamase inhibitorsVENATORX PHARMACEUTICALS INC·Filed 2013·Granted Aug 23, 2016·22 cites·21 claims
- 1693US9944658B2Beta-lactamase inhibitorsVENATORX PHARMACEUTICALS INC·Filed 2014·Granted Apr 17, 2018·10 cites·19 claims
- 1793US9926336B2Beta-lactamase inhibitorsVENATORX PHARMACEUTICALS INC·Filed 2017·Granted Mar 27, 2018·12 cites·20 claims
- 1892US10294247B2Beta-lactamase inhibitorsVENATORX PHARMACEUTICALS INC·Filed 2017·Granted May 21, 2019·6 cites·20 claims
- 1991US11008346B2Beta-lactamase inhibitorsVENATORX PHARMACEUTICALS INC·Filed 2020·Granted May 18, 2021·2 cites·20 claims
- 2091US10125152B2Beta-lactamase inhibitorsVENATORX PHARMACEUTICALS INC·Filed 2017·Granted Nov 13, 2018·8 cites·20 claims
- 2190US11091505B2Solid forms and combination compositions comprising a beta-lactamase inhibitor and uses thereofVENATORX PHARMACEUTICALS INC·Filed 2018·Granted Aug 17, 2021·4 cites·19 claims
- 2289US2025236632A1Beta-lactamase inhibitorsVENATORX PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 2388US8821877B2Methods for inhibiting HIV-1 replication involving the administration of an anti-CCR5 receptor monoclonal antibody and small molecule CCR5 receptor antagonistOLSON WILLIAM C·Filed 2010·Granted Sep 2, 2014·10 cites·19 claims
- 2487US11820784B2Solid forms and combination compositions comprising a beta-lactamase inhibitor and uses thereofVENATORX PHARMACEUTICALS INC·Filed 2021·Granted Nov 21, 2023·1 cites·20 claims
- 2584US12187752B2Solid forms and combination compositions comprising a beta-lactamase inhibitor and uses thereofVENATORX PHARMACEUTICALS INC·Filed 2023·Granted Jan 7, 2025·0 cites·15 claims
- 2684US10464952B2Beta-lactamase inhibitorsVENATORX PHARMACEUTICALS INC·Filed 2018·Granted Nov 5, 2019·5 cites·13 claims
- 2783US2025320235A1Solid forms and combination compositions comprising a beta-lactamase inhibitor and uses thereofVENATORX PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 2877US8575205B2Compounds, compositions and methods for treating or preventing pneumovirus infection and associated diseasesNITZ THEODORE J·Filed 2012·Granted Nov 5, 2013·3 cites·35 claims
- 2973US6541472B1Compounds, compositions and methods for preventing and treating pestivirus infection and associated diseasesVIROPHARMA INC·Filed 2000·Granted Apr 1, 2003·4 cites·14 claims
- 3072US12102648B2Orally-bioavailable nucleoside analogsVENATORX PHARMACEUTICALS INC·Filed 2023·Granted Oct 1, 2024·0 cites·19 claims
- 3172US6495580B1Compounds, compositions and methods for treating or preventing pneumovirus infection and associated diseasesVIROPHARMA INC·Filed 1999·Granted Dec 17, 2002·16 cites·38 claims
- 3270US11414435B2Beta-lactamase inhibitorsVENATORX PHARMACEUTICALS INC·Filed 2020·Granted Aug 16, 2022·0 cites·20 claims
- 3368US2014377259A1Methods for inhibiting hiv-1 replication involving the administration of an anti-ccr5 receptor monoclonal antibody and small molecule ccr5 receptor antagonistCYTODYN INC·Filed 2014·Application pending·0 cites
- 3467US8202896B2Compounds, compositions and methods for treating or preventing pneumovirus infection and associated diseasesNITZ THEODORE J·Filed 2003·Granted Jun 19, 2012·3 cites·32 claims
- 3567US2008241135A1Methods for reducing viral load in HIV-1-infected patientsPROGENICS PHARM INC·Filed 2007·Application pending·0 cites
- 3663US2020306372A1Methods for reducing viral load in hiv-1 infected patientsCYTODYN INC·Filed 2019·Application pending·0 cites
- 3762US2007026441A1Methods for reducing viral load in HIV-1-infected patientsOLSON WILLIAM C·Filed 2006·Application pending·0 cites
- 3861US8962667B2Compounds, compositions and methods for treating or preventing pneumovirus infection and associated diseasesMICRODOSE THERAPEUTX INC·Filed 2014·Granted Feb 24, 2015·0 cites·30 claims
- 3960US2004127499A1Compounds, compositions and methods for preventing and treating pestivirus infection and associated diseasesPEVEAR DANIEL C·Filed 2003·Application pending·0 cites
- 4059US8846735B2Compounds, compositions and methods for treating or preventing pneumovirus infection and associated diseasesMICRODOSE THERAPEUTX INC·Filed 2013·Granted Sep 30, 2014·0 cites·22 claims
- 4157US10500274B2Methods for reducing viral load in HIV-1 infected patientsCYTODYN INC·Filed 2012·Granted Dec 10, 2019·0 cites·12 claims
- 4257US2003176431A1Compounds, compositions and methods for preventing and treating pestivirus infection and associated diseasesPEVEAR DANIEL C·Filed 2003·Application pending·0 cites
- 4356US5830894AMethods for preventing and treating pestivirus infection and associated diseasesVIROPHARMA INC·Filed 1997·Granted Nov 3, 1998·21 cites·45 claims
- 4455US2004076949A1Methods for identifying inhibitors of helicase activity from hepatitis C virusFiled 2003·Application pending·0 cites
- 4555US2017145037A1Orally bioavailable beta-lactamase inhibitorsVENATORX PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 4652US9321739B2Compounds, compositions and methods for treating or preventing pneumovirus infection and associated diseasesRYS DAVID J·Filed 2011·Granted Apr 26, 2016·0 cites·21 claims
- 4752US2002081574A1Methods for identifying inhibitors of helicase C virusFiled 2001·Application pending·0 cites
- 4851US2015361108A1Orally bioavailable beta-lactamase inhibitorsVENATORX PHARMACEUTICALS INC·Filed 2015·Application pending·0 cites
- 4951US2022054513A1Combination compositions comprising a beta-lactamase inhibitorVENATORX PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 5048US2010178290A1Methods for reducing viral load in HIV-1 infected patientsOLSON WILLIAM C·Filed 2009·Application pending·0 cites
Showing the top 50 of 55 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Daniel C. Pevear files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →